文献速递脑血管病神经重症与神经感染

血清淀粉样蛋白A:卒中相关感染的新型预测标志物

SAA (Serum Amyloid A): A Novel Predictor of Stroke-Associated Infections.
PubMed 文献 · Stroke · 2020-11-09

本研究在283例急性缺血性卒中患者(衍生队列A)和367例患者(独立验证队列B)中评估入院时血清淀粉样蛋白A(SAA)对住院期间卒中相关感染的预测价值。校正单因素分析中显著相关的预测因素后,SAA在队列A(校正OR 1.44,95%CI 1.16-1.79;P=0.001)和队列B(校正OR 1.52,95%CI 1.05-2.22;P=0.028)中均为独立预测因素。将SAA加入最佳回归模型后,队列A的判别准确性从0.76(95%CI 0.69-0.83)提高至0.79(95%CI 0.72-0.86;P<0.001),队列B的AUC从0.75(95%CI 0.70-0.81)提高至0.76(95%CI 0.71-0.82;P<0.038)。

要点

  • 入院时血SAA是缺血性卒中后感染的独立预测因素。
  • SAA可提高对卒中后感染与非感染患者的判别能力。
  • 衍生与验证队列结果一致,支持外部有效性。

核心结论

  • 在缺血性卒中患者中,入院时测定的血SAA是卒中后感染的新型独立预测因素。
  • SAA在衍生队列和验证队列中均改善了感染与非感染患者之间的判别。

研究设计与样本

  • 衍生队列A由283例急性缺血性卒中患者组成,独立验证队列B由367例患者组成。
  • 主要结局为住院期间发生的任何卒中相关感染,依据美国疾病控制与预防中心标准定义。
  • 采用逻辑回归模型分析入院SAA水平与感染发生的关联,并通过ROC曲线下面积评估判别能力。

主要发现

  • 校正单因素分析中与任何感染显著相关的所有预测因素后,SAA在队列A中仍为独立预测因素(校正OR 1.44,95%CI 1.16-1.79;P=0.001)。
  • 校正后SAA在队列B中亦为独立预测因素(校正OR 1.52,95%CI 1.05-2.22;P=0.028)。
  • 将SAA加入不含该标志物的最佳回归模型后,队列A的判别准确性从0.76(95%CI 0.69-0.83)提高至0.79(95%CI 0.72-0.86;P<0.001;似然比检验)。
  • 队列B外部验证显示AUC从0.75(95%CI 0.70-0.81)提高至0.76(95%CI 0.71-0.82;P<0.038)。

临床怎么用

  • 入院时检测血SAA可能有助于识别缺血性卒中后感染高风险患者。
  • SAA可作为现有预测模型之外的补充标志物,提升感染风险判别。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: The aim of this study was to evaluate and independently validate SAA (serum amyloid A)-a recently discovered blood biomarker-to predict poststroke infections. METHODS: The derivation cohort (A) was composed of 283 acute ischemic stroke patients and the independent validation cohort (B), of 367 patients. The primary outcome measure was any stroke-associated infection, defined by the criteria of the US Centers for Disease Control and Prevention, occurring during hospitalization. To determine the association of SAA levels on admission with the development of infections, logistic regression models were calculated. The discriminatory ability of SAA was assessed, by calculating the area under the receiver operating characteristic curve. RESULTS: After adjusting for all predictors that were significantly associated with any infection in the univariate analysis, SAA remained an independent predictor in study A (adjusted odds ratio, 1.44 [95% CI, 1.16-1.79]; P=0.001) and in study B (adjusted odds ratio, 1.52 [1.05-2.22]; P=0.028). Adding SAA to the best regression model without the biomarker, the discriminatory accuracy improved from 0.76 (0.69-0.83) to 0.79 (0.72-0.86; P<0.001; likelihood ratio test) in study A. These results were externally validated in study B with an improvement in the area under the receiver operating characteristic curve, from 0.75 (0.70-0.81) to 0.76 (0.71-0.82; P<0.038). CONCLUSIONS: Among patients with ischemic stroke, blood SAA measured on admission is a novel independent predictor of infection after stroke. SAA improved the discrimination between patients who developed an infection compared with those who did not in both derivation and validation cohorts. Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT00390962.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Schweizer J, Bustamante A, Lapierre-Fétaud V, et al. SAA (Serum Amyloid A): A Novel Predictor of Stroke-Associated Infections. Stroke. 2020. PMID: 33161846. doi:10.1161/STROKEAHA.120.030064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。